Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DOSESYSTEM A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3%   Bankruptcy risk   11.6% 3.1% 9.3% 10.1% 15.4% 5.3% 17.6% 17.6%   Credit score (0-100)   22 58 26 23 12 41 9 9   Credit rating   BB BBB BB BB BB BBB B B   Credit limit (kDKK)   -0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   855 2,845 2,278 92.6 525 2,069 0.0 0.0   EBITDA   -209 1,696 372 -1,101 111 2,069 0.0 0.0   EBIT   -1,222 320 -1,056 -2,365 -1,007 472 0.0 0.0   Pre-tax profit (PTP)   -1,652.3 70.0 -1,376.9 -2,659.2 -1,304.3 275.5 0.0 0.0   Net earnings   -1,290.3 -226.2 -948.1 -2,015.0 -1,319.0 215.5 0.0 0.0   Pre-tax profit without non-rec. items   -1,652 70.0 -1,377 -2,659 -1,304 276 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -1,009 700 -248 -2,263 -1,888 -1,673 -2,424 -2,424   Interest-bearing liabilities   564 3,430 4,610 4,899 2,911 3,766 2,424 2,424   Balance sheet total (assets)   3,975 5,828 6,681 4,271 1,896 3,334 0.0 0.0   Net Debt   219 3,090 4,516 4,710 2,889 3,712 2,424 2,424     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   855 2,845 2,278 92.6 525 2,069 0.0 0.0   Gross profit growth   -37.6% 232.7% -19.9% -95.9% 466.9% 294.1% -100.0% 0.0%   Employees   0 3 0 2 1 1 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,975 5,828 6,681 4,271 1,896 3,334 0 0   Balance sheet change%   -10.4% 46.6% 14.6% -36.1% -55.6% 75.9% -100.0% 0.0%   Added value   -208.9 1,695.8 371.7 -1,101.1 256.5 2,068.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -699 -940 -1,423 -1,852 -1,895 -2,760 -450 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 1.0 -1.0 -2.0 -3.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -142.9% 11.2% -46.3% -2,553.9% -191.9% 22.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -25.9% 5.9% -16.6% -34.7% -19.4% 10.8% 0.0% 0.0%   ROI %   -32.2% 7.4% -21.2% -44.1% -23.3% 13.1% 0.0% 0.0%   ROE %   -60.6% -9.7% -25.7% -36.8% -42.8% 8.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -20.2% 12.0% -3.6% -34.6% -49.9% -33.4% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -104.6% 182.2% 1,214.9% -427.8% 2,612.1% 179.5% 0.0% 0.0%   Gearing %   -55.8% 490.1% -1,857.3% -216.4% -154.2% -225.2% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   50.6% 12.5% 8.0% 6.8% 7.7% 6.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 0.6 0.6 0.3 0.1 0.6 0.0 0.0   Current Ratio   1.1 0.6 0.6 0.3 0.1 0.6 0.0 0.0   Cash and cash equivalent   345.1 340.4 94.5 188.4 21.4 54.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   144.7 -1,721.5 -2,550.3 -4,254.2 -3,084.1 -1,958.9 -1,211.8 -1,211.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 565 0 -551 257 2,069 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 565 0 -551 111 2,069 0 0   EBIT / employee   0 107 0 -1,182 -1,007 472 0 0   Net earnings / employee   0 -75 0 -1,008 -1,319 215 0 0